How #AI looks in Dynamika. Automatic #glioblastoma #GBM segmentation: green oedema, red enhancing tumour and blue necrosis. Read more here: lnkd.in/e4Cevtm IAG, IMAGE ANALYSIS GROUP with Jamshid Dehmeshki Olga Kubassova, MMath, PhD Michael Clark…lnkd.in/emsM6yx

IAG’s team will be attending MedInvest Cardiovascular & Nuerovascular Conference, 2020, with objective is to meet clinical stage biotech companies developing novel treatments to address patients’ needs. IAG, IMAGE ANALYSIS GROUP lnkd.in/d4jKz23

Congratulations Sotirios Bisdas Well deserved! IAG, IMAGE ANALYSIS GROUP lnkd.in/dJhTr9H

IAG, IMAGE ANALYSIS GROUP’s team will be attending Biotech Showcase’21, leading #biotech #investment and #partnering forum! We are here to create long-lasting partnerships with #lifescience companies looking to lower the costs and…lnkd.in/dFnJsD4 lnkd.in/dTtu8bZ

lnkd.in/dCxe2sa

It's a great pleasure to announce IAG, IMAGE ANALYSIS GROUP partnership with WPD Pharmaceuticals Inc. to advance the development of the Berubicin, novel treatment for #glioblastoma. "The integration of advanced #imaging and #AI dr…lnkd.in/dRYdvpK lnkd.in/dNNzpqV

Looking forward to my talk at the University of Miami's Brain Tumor Initiative and have insightful discussions with the team on the role of advanced imaging in #neurooncology and #Neurosurgery. The focus of my talk will be advance…lnkd.in/datq9jg lnkd.in/dWZhRg2

CD161-CLEC2D pathway potential new target for #immunotherapy in diffuse #glioma. Dana-Farber Cancer Institute Massachusetts General Hospital Broad Institute of MIT and Harvard #oncology #neuroscience #neurooncology lnkd.in/dz35W94

Oblato receives #FDA fast track designation for OKN-007 in children with Diffuse Intrinsic Pontine #Glioma #DIPGG). DIPG is a highly aggressive and difficult to treat type of brain tumor. Most diagnoses occurring between 5 and 7 y…lnkd.in/dVcUn-z lnkd.in/diQGjnB

Join WPD Pharmaceuticals Inc. ’s CEO MO and myself in a live webinar to discuss the potential of advanced imaging to show early treatment effects of #berubicin in #braincancer. Thursday, April 15th 2021, 1 PM ET / 6 P…lnkd.in/dAQDPWj lnkd.in/dd58JPp

Researchers developed a cerebral organoid-based 3D model of human #glioblastoma #GBM to replicate its fundamental biology. The 3D organoid allows to study the behavior of the tumor microenvironment and test potential drugs. The tec…lnkd.in/d-dy_MW lnkd.in/dHq5X8t

#Glioblastoma drug development is probably the most complex area of #oncology clinical research. Today MO and I will present how #imaging and artificial intelligence #AI driven imaging biomarkers can advance neuro-onco…lnkd.in/dqa8nU6 lnkd.in/dd58JPp

Delighted to announce I have joined APEX Ventures #VC Looking for early-stage #deeptech #medtech #digitalhealth #robotics #fertility #longevity #computervision

Superventure conference. Great discussion on #healthTech post #covid by Leila Rastegar Zegna #SuperReturn #apexventures

Backstage and Stage: our all woman panel at SuperReturn on value-based care APEX Ventures

Thank you BlueYard Capital for an insightful and delicious evening focusing on #venturecapital in Programmable Biology.

Excited to be part of the journey! CardiaTec raises £1.4m to tackle heart disease with AI uktech.news/medtech/cardia…

Honoured to be on Health Tech World Incredible Women list htworld.co.uk/news/revealed-…

Inspirational discussions with Lyfegen on the dynamics of value-based care in Europe vs the US. Lyfegen is an APEX Ventures medical portfolio company, revolutionizing how drugs are priced and reimbursed via their joint value-based contracting platform.

Bringing my own chair to the board meeting. Early education for little V